Old Web
English
Sign In
Acemap
>
authorDetail
>
Shu-Ling Rong
Shu-Ling Rong
Shanxi Medical University
Internal medicine
Medicine
Myocardial infarction
Hepatocyte growth factor
Cardiology
4
Papers
27
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and safety of stem cell therapy in patients with dilated cardiomyopathy: a systematic appraisal and meta-analysis.
2019
Journal of Translational Medicine
Shu-Ling Rong
Z. Wang
Xuedong Zhou
Xiao-Lin Wang
Zhi-Ming Yang
Bao Li
Show All
Source
Cite
Save
Citations (4)
Glutathione S-Transferase M1 and T1 polymorphisms and hypertension risk: an updated meta-analysis
2018
Journal of Human Hypertension
Shu-Ling Rong
Xue Dong Zhou
Z. Wang
Xiao-Lin Wang
Yu-chuan Wang
Cun-shui Xue
Bao Li
Show All
Source
Cite
Save
Citations (5)
Anti-inflammatory activities of hepatocyte growth factor in post-ischemic heart failure
2018
Acta Pharmacologica Sinica
Shu-Ling Rong
Xiao-Lin Wang
Yi-cheng Wang
Huan Wu
Xue Dong Zhou
Z. Wang
Yu-chuan Wang
Cun-shui Xue
Bao Li
Dong-lai Gao
Show All
Source
Cite
Save
Citations (7)
Transplantation of HGF gene-engineered skeletal myoblasts improve infarction recovery in a rat myocardial ischemia model
2017
PLOS ONE
Shu-Ling Rong
Xiao-Lin Wang
Cui-Ying Zhang
Zhuo-Hui Song
Lu-Hua Cui
Xiao-feng He
Xu-Jiong Li
Hui-Jin Du
Bao Li
Show All
Source
Cite
Save
Citations (11)
1